blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3428650

EP3428650 - METHOD FOR QUANTIFYING COGNITIVE DYSFUNCTION DISEASE BIOMARKER USING MASS SPECTROMETRY AND MASS SPECTROMETER [Right-click to bookmark this link]
StatusThe application has been withdrawn
Status updated on  08.11.2019
Database last updated on 13.09.2024
FormerRequest for examination was made
Status updated on  14.12.2018
Most recent event   Tooltip08.11.2019Withdrawal of applicationpublished on 11.12.2019  [2019/50]
Applicant(s)For all designated states
Shimadzu Corporation
1, Nishinokyo-Kuwabara-cho
Nakagyo-ku
Kyoto-shi
Kyoto 604-8511 / JP
[2019/03]
Inventor(s)01 / MATSUBARA, Toshiya
c/o Shimadzu Corporation
1, Nishinokyo-Kuwabara-cho
Nakagyo-ku
Kyoto-shi, Kyoto 604-8511 / JP
02 / KAWAKAMI, Daisuke
c/o Shimadzu Corporation
1, Nishinokyo-Kuwabara-cho
Nakagyo-ku
Kyoto-shi, Kyoto 604-8511 / JP
 [2019/03]
Representative(s)Mewburn Ellis LLP
Aurora Building
Counterslip
Bristol BS1 6BX / GB
[N/P]
Former [2019/03]Webster, Jeremy Mark, et al
Mewburn Ellis LLP
City Tower
40 Basinghall Street
London EC2V 5DE / GB
Application number, filing date18183279.112.07.2018
[2019/03]
Priority number, dateJP2017013772514.07.2017         Original published format: JP 2017137725
[2019/03]
Filing languageJA
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP3428650
Date:16.01.2019
Language:EN
[2019/03]
Type: A3 Search report 
No.:EP3428650
Date:01.05.2019
Language:EN
[2019/18]
Search report(s)(Supplementary) European search report - dispatched on:EP29.03.2019
ClassificationIPC:G01N33/68
[2019/03]
CPC:
G01N33/6896 (EP,US); G01N30/02 (CN); C12Q1/34 (EP,US);
C12Q1/48 (EP,US); C12Q1/56 (EP,US); G01N30/72 (CN);
G01N33/6848 (EP,US); H01J49/0031 (EP,US); H01J49/004 (US);
H01J49/0045 (EP,US); H01J49/4215 (US); G01N2800/28 (EP,US);
H01J49/0036 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/03]
Extension statesBANot yet paid
MENot yet paid
Validation statesKHNot yet paid
MANot yet paid
MDNot yet paid
TNNot yet paid
TitleGerman:VERFAHREN ZUR QUANTIFIZIERUNG VON BIOMARKERN FÜR KOGNITIVE DYSFUNKTIONSKRANKHEITEN MITTELS MASSENSPEKTROMETRIE UND MASSENSPEKTROMETER[2019/03]
English:METHOD FOR QUANTIFYING COGNITIVE DYSFUNCTION DISEASE BIOMARKER USING MASS SPECTROMETRY AND MASS SPECTROMETER[2019/03]
French:PROCÉDÉ DE QUANTIFICATION DE BIOMARQUEURS DE LA MALADIE DE DYSFONCTIONNEMENT COGNITIF AU MOYEN DE LA SPECTROMÉTRIE DE MASSE ET SPECTROMÈTRE DE MASSE[2019/03]
Examination proceduredeletedDate on which the examining division has become responsible
12.07.2018Examination requested  [2019/03]
07.11.2019Application withdrawn by applicant  [2019/50]
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[I]EP2657706  (MCBI INC [JP]) [I] 1-4 * par. 0016, 0018, 0031, 0033, 0038, 0039, 0061, 0062, 0065, 0066, 0069- 0072, 0075, 0076, 0082, 0083 *;
 [A]EP2444814  (MCBI INC [JP]) [A] 1-4 * par. 0015, 0016, 0018, 0045, 0046, 0054, 0066-0073;; claims 8,9,12,13; sequences 2, 4, 6, *;
 [AD]JP2012037349  (MCBI:KK) [AD] 1-4 * par.0014, 0015, 0017, 0032, 0034, 0035, 0042, 0045;; claims 5-7; sequence 6 *;
 [A]  - VAN DEN BROEK I ET AL, "Quantitative assay for six potential breast cancer biomarker peptides in human serum by liquid chromatography coupled to tandem mass spectrometry", JOURNAL OF CHROMATOGRAPHY B: BIOMEDICAL SCIENCES & APPLICATIONS, ELSEVIER, AMSTERDAM, NL, vol. 878, no. 5-6, doi:10.1016/J.JCHROMB.2010.01.011, ISSN 1570-0232, (20100215), pages 590 - 602, (20100118), XP026886266 [A] 1,2 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.jchromb.2010.01.011
 [A]  - J. A. MEAD ET AL, "MRMaid, the Web-based Tool for Designing Multiple Reaction Monitoring (MRM) Transitions", MOLECULAR & CELLULAR PROTEOMICS, US, (20081115), vol. 8, no. 4, doi:10.1074/mcp.M800192-MCP200, ISSN 1535-9476, pages 696 - 705, XP055384446 [A] 1-4 * abstract *

DOI:   http://dx.doi.org/10.1074/mcp.M800192-MCP200
by applicantJP2010271078
 JP2012037349
 JP2012132808
 JP2016028243
 JP2016028244
 WO2014207888
    - Yoku wakaru arutsuhaimah byo—jissaini kakawaru hitono tameni (Alzheimer's Disease Understood Well-For Actual Participants
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.